- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer Therapy–Associated Thrombosis
Authors
Keywords
-
Journal
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-02-11
DOI
10.1161/atvbaha.120.314378
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Doxorubicin contributes to thrombus formation and vascular injury via enhancing platelet functions in vivo
- (2020) Haichen Lv et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trials
- (2020) Kyaw Zin Thein et al. BREAST CANCER RESEARCH AND TREATMENT
- Thrombosis in hematological malignancies: mechanisms and implications
- (2020) Netanel A. Horowitz et al. THROMBOSIS RESEARCH
- Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study
- (2020) Florian Moik et al. Cancers
- Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review
- (2020) Cinzia Solinas et al. THROMBOSIS RESEARCH
- Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib
- (2019) Yllka Latifi et al. BLOOD
- Ponatinib Tyrosine Kinase Inhibitor Induces a Thromboinflammatory Response
- (2019) Abdullah Hamadi et al. THROMBOSIS AND HAEMOSTASIS
- Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring
- (2019) Nadine Wenningmann et al. MOLECULAR PHARMACOLOGY
- Arterial Thrombosis in Cancer: Spotlight on the Neglected Vessels
- (2019) MARIA LAURA CANALE et al. ANTICANCER RESEARCH
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
- (2019) Nigel S. Key et al. JOURNAL OF CLINICAL ONCOLOGY
- Venous thromboembolism in breast cancer patients receiving cyclin‐dependent kinase inhibitors
- (2019) Lorenzo Gervaso et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Risk of Venous Thromboembolic Events in Patients With Cancer Treated With Aflibercept
- (2018) Raju Kanukula et al. AMERICAN JOURNAL OF THERAPEUTICS
- Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial
- (2018) Jorge E. Cortes et al. BLOOD
- Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer.
- (2018) Ella Grilz et al. HAEMATOLOGICA
- Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events
- (2018) Rhian M. Touyz et al. Journal of the American Society of Hypertension
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Venous thromboembolism with EGFR monoclonal antibody necitumumab in stage IV non-small cell lung cancer: A retrospective cohort analysis
- (2018) Kelvin Young et al. THROMBOSIS RESEARCH
- Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer.
- (2018) Ella Grilz et al. HAEMATOLOGICA
- Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
- (2018) Kulmira Nurgali et al. Frontiers in Pharmacology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Correlation of the tamoxifen use with the increased risk of deep vein thrombosis and pulmonary embolism in elderly women with breast cancer
- (2018) Hsien-Feng Lin et al. MEDICINE
- MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
- (2017) Matthew P. Goetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidermal growth factor receptor in glioblastoma
- (2017) Hongsheng Xu et al. Oncology Letters
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer
- (2017) Eric S. Kim et al. PLoS One
- Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
- (2016) Hélène Haguet et al. Expert Opinion On Drug Safety
- Systematic review and meta-analysis of the risk of severe and life-threatening thromboembolism in cancer patients receiving anti-EGFR monoclonal antibodies (cetuximab or panitumumab)
- (2016) Marco Miroddi et al. INTERNATIONAL JOURNAL OF CANCER
- Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial
- (2016) Jeffrey H Lipton et al. LANCET ONCOLOGY
- The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic state
- (2016) Naif Alhawiti et al. THROMBOSIS RESEARCH
- Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma
- (2016) K.M. Sanfilippo et al. THROMBOSIS RESEARCH
- Risk of venous and arterial thromboembolic events associated with anti-VEGF agents in advanced non-small-cell lung cancer: a meta-analysis and systematic review
- (2016) Xianfen Zhang et al. OncoTargets and Therapy
- Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival
- (2016) Jonathan Douxfils et al. JAMA Oncology
- Massive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapy
- (2016) Kelly Aubertin et al. Scientific Reports
- Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy withl-asparaginase: The GRAALL experience
- (2015) Marie-Anne Couturier et al. AMERICAN JOURNAL OF HEMATOLOGY
- The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents
- (2015) Christopher M. Tully et al. CANCER
- The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
- (2015) Richard S Finn et al. LANCET ONCOLOGY
- Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma
- (2015) Ni Chen et al. Molecular Cancer
- Epidemiology of venous thromboembolism
- (2015) John A. Heit Nature Reviews Cardiology
- Approach to chemotherapy-associated thrombosis
- (2015) Peter Oppelt et al. VASCULAR MEDICINE
- Effects of 5-Fluorouracil on Morphology, Cell Cycle, Proliferation, Apoptosis, Autophagy and ROS Production in Endothelial Cells and Cardiomyocytes
- (2015) Chiara Focaccetti et al. PLoS One
- Defective Angiogenesis Delays Thrombus Resolution
- (2014) Sherin Alias et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Antiangiogenic Therapy Inhibits Venous Thrombus Resolution
- (2014) Colin E. Evans et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors
- (2014) P. Valent et al. BLOOD
- Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: An up-to-date meta-analysis
- (2014) Wei-Xiang Qi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation
- (2014) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy
- (2014) Wouter W. Mellema et al. LUNG CANCER
- Exosomes: Decreased Sensitivity of Lung Cancer A549 Cells to Cisplatin
- (2014) Xia Xiao et al. PLoS One
- Tamoxifen induces resistance to activated protein C
- (2014) Heiko Rühl et al. THROMBOSIS RESEARCH
- Epidemiology of cancer-associated venous thrombosis
- (2013) J. F. Timp et al. BLOOD
- Risk of venous and arterial thromboembolic events in cancer patients treated with gemcitabine: a systematic review and meta-analysis
- (2013) Wei-Xiang Qi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Venous thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A systematic review and meta-analysis of randomized clinical trials
- (2013) Guru Sonpavde et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
- (2013) Jesus San Miguel et al. LANCET ONCOLOGY
- A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
- (2013) J.E. Cortes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide Treatment for Multiple Myeloma: Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2013) Bo Yang et al. PLoS One
- Doxorubicin-Induced Vascular Toxicity – Targeting Potential Pathways May Reduce Procoagulant Activity
- (2013) Irit Ben Aharon et al. PLoS One
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- Venous thromboembolism in adults treated for acute lymphoblastic leukaemia: Effect of fresh frozen plasma supplementation
- (2013) Bronno van der Holt et al. THROMBOSIS AND HAEMOSTASIS
- Risk of venous and arterial thromboembolic events associated with anti-EGFR agents: a meta-analysis of randomized clinical trials
- (2012) F. Petrelli et al. ANNALS OF ONCOLOGY
- Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States
- (2012) Alok A. Khorana et al. CANCER
- Risk of venous thromboembolic events associated with VEGFR-TKIs: A systematic review and meta-analysis
- (2012) Wei-Xiang Qi et al. INTERNATIONAL JOURNAL OF CANCER
- Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responsesin Vitro
- (2012) Li-Hong Lv et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs
- (2012) Saroj Niraula et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of Venous Thromboembolism in Patients With Cancer Treated With Cisplatin: A Systematic Review and Meta-Analysis
- (2012) Sonia Seng et al. JOURNAL OF CLINICAL ONCOLOGY
- Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis
- (2012) Tracy Proverbs-Singh et al. JNCI-Journal of the National Cancer Institute
- Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis
- (2012) M. CARRIER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The coagulopathy and thrombotic risk associated with L-Asparaginase treatment in adults with acute lymphoblastic leukaemia
- (2012) E Truelove et al. LEUKEMIA
- Hemostatic changes after 1 month of thalidomide and dexamethasone therapy in patients with multiple myeloma
- (2012) Marta Robak et al. MEDICAL ONCOLOGY
- Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients
- (2012) Lisa G. van den Hengel et al. THROMBOSIS RESEARCH
- EGFR Mutations and Lung Cancer
- (2011) Gilda da Cunha Santos et al. Annual Review of Pathology-Mechanisms of Disease
- Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
- (2011) Y. X. Zhu et al. BLOOD
- Defibrotide Blunts the Prothrombotic Effect of Thalidomide on Endothelial Cells
- (2011) C. L. Echart et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
- (2011) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Venous Thromboembolic Events With Chemotherapy Plus Bevacizumab: A Pooled Analysis of Patients in Randomized Phase II and III Studies
- (2011) Herbert I. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus
- (2011) L. L. SWYSTUN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis
- (2011) M. CARRIER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Impact of Chemotherapy on Thrombin Generation and on the Protein C Pathway in Breast Cancer Patients
- (2011) Som D. Mukherjee et al. pathophysiology of haemostasis and thrombosis
- Anti-thrombotic effects of selective estrogen receptor modulator tamoxifen
- (2011) Manasa Nayak et al. THROMBOSIS AND HAEMOSTASIS
- Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity
- (2011) Jeremiah C. Boles et al. THROMBOSIS RESEARCH
- Tamoxifen promotes superoxide production in platelets by activation of PI3-Kinase and NADPH oxidase pathways
- (2011) Vidhi P. Shah et al. THROMBOSIS RESEARCH
- Doxorubicin-Induced Platelet Procoagulant Activities: An Important Clue for Chemotherapy-Associated Thrombosis
- (2011) Se-Hwan Kim et al. TOXICOLOGICAL SCIENCES
- Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis of randomized controlled trials
- (2010) Vishal Ranpura et al. ACTA ONCOLOGICA
- Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes
- (2010) F. A. B. Schutz et al. ANNALS OF ONCOLOGY
- Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: A retrospective study
- (2010) Luigi Gugliotta et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Risk of Arterial Thrombosis Not Increased by Sorafenib or Sunitinib
- (2010) David R. Minor JOURNAL OF CLINICAL ONCOLOGY
- Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials
- (2010) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Biology of Anti-Angiogenic Therapy–Induced Thrombotic Microangiopathy
- (2010) Vera Eremina et al. SEMINARS IN NEPHROLOGY
- Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma
- (2010) J. J. A. Auwerda et al. THROMBOSIS AND HAEMOSTASIS
- A novel role for tamoxifen in the inhibition of human platelets
- (2010) Yi Chang et al. Translational Research
- Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia
- (2009) Pascale Schneider et al. BRITISH JOURNAL OF HAEMATOLOGY
- Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism
- (2009) Rohini K. Hernandez et al. CANCER
- Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes
- (2009) L. L. SWYSTUN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
- (2009) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics
- (2009) Shankaranarayana Paneesha et al. THROMBOSIS AND HAEMOSTASIS
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study
- (2008) M. Hunault-Berger et al. HAEMATOLOGICA
- Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients
- (2008) Shobha Rani Nalluri et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
- (2008) Salah-Eddin Al-Batran et al. JOURNAL OF CLINICAL ONCOLOGY
- VEGF Inhibition and Renal Thrombotic Microangiopathy
- (2008) Vera Eremina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started